Summarising our view on 'insight'

Over on my other blog, I laid out an overview of ‘insight’ in pharma positioning and market research.

Using NotebookLM, here’s a summary of that post:

Limitations of Traditional Market Research and IDEA Pharma's Approach

Traditional market research methods in the pharmaceutical industry often fall short due to several limitations:

●

Focus on "Unmet Needs": Traditional research frequently centres around identifying "unmet needs." However, this approach presumes customers have already considered all possibilities and can articulate what they lack. In reality, customers might not fully grasp what is possible, especially with innovative products. They may simply express a desire for more efficacy, safety, tolerability, or options—generic responses that don't offer actionable insights.

●

Framing by the Present: Conventional market research tends to be constrained by the "now." Customers, particularly physicians, often have limited visibility into future therapeutic advancements beyond 3–6 months. This short-sightedness results in research framed by current disease management practices and existing products, failing to capture potential shifts in the future landscape.

●

Lack of Stimulus Material: Traditional methods may not adequately stimulate customers' thinking about potential innovations. Without tangible "prototypes" or representations of future possibilities, customers struggle to provide insightful feedback on what they truly desire. They may resort to expressing a desire for a "faster horse," as Henry Ford famously noted.

●

Over-Reliance on Quantitative Data: While quantitative research has its place, over-reliance on it can lead to shallow insights. Simple quantitative approaches, such as conjoint analysis, might not capture the nuanced goals and behavioural drivers that underlie prescribing decisions. Qualitative interviews, with their ability to explore motivations and contexts, are often more effective in uncovering deep insights.

IDEA Pharma's Strategy

IDEA Pharma addresses these limitations by:

●

Shifting Focus from "Needs" to "Goals": Instead of fixating on "unmet needs," IDEA Pharma focuses on understanding the goals of the target audience. This shift is crucial because goals, unlike needs, are directly linked to behaviours and provide a more actionable basis for strategy.

●

Employing Prototype-Driven Research: IDEA Pharma utilises "prototypes" to stimulate thought and discussion. These prototypes aren't literal products but rather representations of potential product profiles or therapeutic approaches. By presenting these prototypes to potential users, IDEA Pharma elicits feedback on what resonates and aligns with their goals, even if users can't articulate those goals directly.

●

Iterative and Collaborative Approach: IDEA Pharma acknowledges that insightful research is an iterative process. They work with market research (MR) teams, providing stimulus material and "snorkeling around the surface" to generate initial clues. These clues are then fed back to MR teams for "deeper dives" to uncover more differentiated insights.

●

Emphasis on Understanding Behavioural Drivers: IDEA Pharma goes beyond simply identifying what customers say they want or need. Their research aims to uncover the underlying drivers of behaviour. This involves understanding the context of prescribing decisions—for instance, how practice settings like an emergency room (ER) versus a primary care physician (PCP) might influence choices. This deep understanding of motivations helps to inform more effective strategies.